SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549


                           ---------------------------


                                    FORM 8-K


                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



Date of Report                                April 2, 2003
(Date of earliest event reported)             ----------------------------------

                           MedicaLogic/Medscape, Inc.
               (Exact name of registrant as specified in charter)


       Oregon                  000-28285           93-0890696
--------------------------------------------------------------------------------

   (State or other     (Commission file         (IRS employer
   jurisdiction              number)            identification no.)
   of incorporation)

                           20540 NW Evergreen Parkway
                             Hillsboro, Oregon 97124
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


Registrant's telephone number,               (503) 531-7000
including area code                          -----------------------------------

                                 Not applicable
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)


<PAGE>


     Item 5. Other Events

     On January 24,  2002,  MedicaLogic/Medscape, Inc.  (the  "Company") and its
five United  States  subsidiaries  filed a  voluntary  petition  for  bankruptcy
protection  (collectively,  the "Bankruptcy Cases") under Chapter 11 of the U.S.
Bankruptcy  Code (the  "Code") in the  United  States  Bankruptcy  Court for the
District  of  Delaware  (the  "Bankruptcy  Court").  The  Bankruptcy  Cases were
assigned to the Honorable Judge Peter J. Walsh and are jointly administered and
coordinated  under Case Numbers  02-10253 (PJW) through  02-10258  (PJW). In
addition  to  the  Company,   the  filing  entities  were  MSCP  Holdings, Inc.,
MedicaLogic  Enterprises, Inc.,  MedicaLogic  Pennsylvania,  LLC, MedicaLogic of
Texas, Inc.  and MedicaLogic Texas, L.P.  (collectively,  with the Company,  the
"Debtors").

     On November 22, 2002,  the Debtors  filed a Joint Plan of  Liquidation  and
related  Disclosure  Statement in the Bankruptcy  Court pursuant to the Code. On
December 20, 2003,  the Debtors filed a First Amended Joint Plan of  Liquidation
(the "Plan") and related First Amended Disclosure Statement. The Court confirmed
the  Plan on March  3,  2003.  On April 3,  2003,  the  Debtors  filed  with the
Bankruptcy Court a Notice of (1) Entry of Confirmation  Order, (2) Occurrence of
Effective Date, and (3) Important Bar Dates announcing, among other things, that
the  effective  date of the Plan occurred on April 2, 2003 (the  "Notice").  The
Notice is attached hereto as Exhibit 99.1


Item 7.  Financial Statements and Exhibits.

           (c)  Exhibits

================================================================================
Exhibit No.              Description

 99.1                    Notice of (1) Entry of Confirmation Order,
                         (2) Occurrence of Effective Date, and (3) Important
                         Bar Dates
================================================================================
<PAGE>



                                    SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Company  has  duly  caused  this  report  to be  signed  on  its  behalf  by the
undersigned hereunto duly authorized.

Date:  April 8, 2003



                                         MEDICALOGIC/MEDSCAPE, INC.


                                         By: /s/ Hobart T. Truesdall
                                             -----------------------------------
                                             Name:  Hobart T. Truesdall
                                             Title: Trustee
<PAGE>


                                  EXHIBIT INDEX
================================================================================

     99.1            Notice of (1) Entry of Confirmation Order, (2) Occurrence
                     of Effective Date, and (3) Important Bar Dates
================================================================================
[{"type": "8-K", "sequence": "1", "filename": "medicalogic8k040203.txt", "description": "8K, MAIN TEXT", "secsgml_size_bytes": 4515}]
{"company-data": {"conformed-name": "MEDICALOGIC/MEDSCAPE INC", "cik": "0000923899", "assigned-sic": "7374", "irs-number": "930890696", "state-of-incorporation": "OR", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28285", "film-number": "03642579"}, "business-address": {"street1": "20500 NW EVERGREEN PARKWAY", "street2": "STE 400", "city": "HILLSBORO", "state": "OR", "zip": "97124", "phone": "5035317000"}, "mail-address": {"street1": "20500 NW EVERGREEN PARKWAY", "city": "HILLSBORO", "state": "OR", "zip": "97124"}, "former-company": {"former-conformed-name": "MEDICALOGIC INC", "date-changed": "19990818"}}
SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                           ---------------------------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

Date of Report                                April 2, 2003
(Date of earliest event reported)             ----------------------------------

                           MedicaLogic/Medscape, Inc.
               (Exact name of registrant as specified in charter)

       Oregon                  000-28285           93-0890696
--------------------------------------------------------------------------------

   (State or other     (Commission file         (IRS employer
   jurisdiction              number)            identification no.)
   of incorporation)

                           20540 NW Evergreen Parkway
                             Hillsboro, Oregon 97124
--------------------------------------------------------------------------------
                    (Address of principal executive offices)

Registrant's telephone number,               (503) 531-7000
including area code                          -----------------------------------

                                 Not applicable
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)
Item 5. Other Events

     On January 24,  2002,  MedicaLogic/Medscape, Inc.  (the  "Company") and its
five United  States  subsidiaries  filed a  voluntary  petition  for  bankruptcy
protection  (collectively,  the "Bankruptcy Cases") under Chapter 11 of the U.S.
Bankruptcy  Code (the  "Code") in the  United  States  Bankruptcy  Court for the
District  of  Delaware  (the  "Bankruptcy  Court").  The  Bankruptcy  Cases were
assigned to the Honorable Judge Peter J. Walsh and are jointly administered and
coordinated  under Case Numbers  02-10253 (PJW) through  02-10258  (PJW). In
addition  to  the  Company,   the  filing  entities  were  MSCP  Holdings, Inc.,
MedicaLogic  Enterprises, Inc.,  MedicaLogic  Pennsylvania,  LLC, MedicaLogic of
Texas, Inc.  and MedicaLogic Texas, L.P.  (collectively,  with the Company,  the
"Debtors").

     On November 22, 2002,  the Debtors  filed a Joint Plan of  Liquidation  and
related  Disclosure  Statement in the Bankruptcy  Court pursuant to the Code. On
December 20, 2003,  the Debtors filed a First Amended Joint Plan of  Liquidation
(the "Plan") and related First Amended Disclosure Statement. The Court confirmed
the  Plan on March  3,  2003.  On April 3,  2003,  the  Debtors  filed  with the
Bankruptcy Court a Notice of (1) Entry of Confirmation  Order, (2) Occurrence of
Effective Date, and (3) Important Bar Dates announcing, among other things, that
the  effective  date of the Plan occurred on April 2, 2003 (the  "Notice").  The
Notice is attached hereto as Exhibit 99.1

Item 7.  Financial Statements and Exhibits.

           (c)  Exhibits

================================================================================
Exhibit No.              Description

 99.1                    Notice of (1) Entry of Confirmation Order,
                         (2) Occurrence of Effective Date, and (3) Important
                         Bar Dates
================================================================================
SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Company  has  duly  caused  this  report  to be  signed  on  its  behalf  by the
undersigned hereunto duly authorized.

Date:  April 8, 2003

                                         MEDICALOGIC/MEDSCAPE, INC.

                                         By: /s/ Hobart T. Truesdall
                                             -----------------------------------
                                             Name:  Hobart T. Truesdall
                                             Title: Trustee
EXHIBIT INDEX
================================================================================

     99.1            Notice of (1) Entry of Confirmation Order, (2) Occurrence
                     of Effective Date, and (3) Important Bar Dates
================================================================================